Dipòsit Digital de Documents de la UAB
Publication
Artículo científico (JournalArticle)
Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study
HIV-1/HAART-associated lipodystrophy syndrome (HALS) has been associated with exposure to stavudine (d4T) through mitochondrial dysfunction. We performed a 48-week study to assess the effects of switching from d4T to raltegravir (RAL) on metabolic and fat molecular parameters of patients with HALS. Forty-two patients with HALS and a median exposure to d4T.
Project:
Instituto de Salud Carlos III FIS08/00256
,
Instituto de Salud Carlos III PI11/1512
,
Instituto de Salud Carlos III FIPSE36610
,
Instituto de Salud Carlos III FIPSE36572/06
,
Instituto de Salud Carlos III FIPSE36697/07
,
Instituto de Salud Carlos III RISRD12/0017/0014
,
Ministerio de Sanidad y Consumo RD06/0006/0005
,
Instituto de Salud Carlos III INT12/383
,
Instituto de Salud Carlos III INT13/232